News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
finance.yahoo.com Analyst action
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. DexCom's latest analyst work shows a modest lift in the modelled fair value, with the price target figure moving from US$91.64 to US$94.12. This adjustment sits alongside mixed …
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Bridgewater Advisors Inc. has acquired a new position in DexCom, Inc. (NASDAQ:DXCM) by purchasing 12,347 shares valued at approximately $1.08 million during the second quarter. This investment is part of a broader trend of institutional interest, with several other firms increasing their stakes in …
Analysts have issued a "Moderate Buy" consensus rating for IDEXX Laboratories (NASDAQ:IDXX), with six buy ratings and four holds among ten covering brokerages. The average 12-month price target is $747, and the company recently surpassed quarterly earnings expectations with $4.27 EPS and $1.22 billion …
For decades, FedEx built out one of the country's largest delivery networks as Americans sent and ordered more packages. Now the delivery giant is rebuilding parts of that network from the inside out. Facilities that once operated separately are being combined, routes have been …
SWS Partners recently acquired 43,005 shares of DexCom, Inc. ($DXCM) during the second quarter, valued at approximately $2.9 million, making them a new institutional investor in the medical device company. Despite some insider selling activity, which was conducted under pre-arranged trading plans, analysts generally …
This article analyzes Addex Therapeutics Ltd (NASDAQ: ADXN), highlighting a positive near-term sentiment but broader weak alignment. It presents an exceptional 60.0:1 risk-reward setup targeting a 20.6% gain against a 0.3% risk. The article outlines institutional trading strategies, including position trading, momentum breakout, and …
Wall Street Zen has downgraded Codexis (NASDAQ:CDXS) from "Hold" to "Sell," causing the stock to fall 2.5% to $1.56, significantly below its 12-month high. Despite beating quarterly earnings expectations with a smaller loss and higher revenue than anticipated, the biotechnology company remains unprofitable, with …
This article provides a list of Exchange Traded Funds (ETFs) that hold DexCom, Inc. stocks, sorted by market value. It highlights how these funds can make investing in stocks more accessible and offer diversified opportunities with lower risk. The list includes various ETFs from …
IDEXX Laboratories unveiled its growth strategy at Investor Day, targeting a $45 billion pet diagnostics market. The company plans to expand its diagnostic testing through AI, new platforms like inVue Dx and MultiCue Dx, and by enhancing cancer detection panels. IDEXX aims to improve …
Shares of DexCom Inc. (DXCM) fell by 1.89% to $89.75 on Friday, underperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average also decline. This drop ended a six-day winning streak for the company's stock.
Kynam Capital Management, LP, along with Kynam Capital Management GP, LLC and Yue Tang, has disclosed a beneficial ownership of 6.78% in Celldex Therapeutics, Inc. This ownership translates to shared voting and dispositive power over 5,322,908 shares of Celldex's common stock. The filing, a …
Codexis (CDXS) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in its earnings estimates. This upgrade suggests a positive outlook for the company's earnings, which historically correlates strongly with stock price movement, making CDXS an attractive investment. The …
T. Rowe Price Associates has disclosed a 6.0% beneficial ownership stake in Celldex Therapeutics Inc. (CLDX) through a Schedule 13G filing. The firm reported holding 4,686,187 shares of common stock, with sole voting power over 4,683,226 shares and sole dispositive power over all 4,686,187 …
Standex International (SXI) reported strong fiscal 2026 results, with revenue reaching $891.6M and diluted EPS of $8.67, significantly up from the prior year. This growth was fueled by both strategic acquisitions and organic expansion, leading to a more than doubling of net income to …
Standex International Corporation (NYSE:SXI) has received a "Moderate Buy" consensus rating from analysts, with four out of five recommending a buy and one a hold. The average 12-month price target is set at $298.67. The company recently reported strong quarterly earnings, beating estimates with …
This article provides a technical analysis of IDEXX Laboratories Inc (IDXX), focusing on its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock has a momentum score of 3.37, trading between a resistance of 605.29 and support …
IDEX Chief Accounting Officer Lisa Anderson recently sold 385 shares of company stock, totaling $91,857.15, reducing her stake by 8.17%. Despite this insider sale, analysts generally maintain a "Moderate Buy" rating for IDEX with an average target price of $260.80, following strong Q2 earnings …
Lisa Anderson, Senior Vice President at IDEX Corp. (NASDAQ:IEX), sold 385 shares of company stock for $91,859 on August 12, 2026, after acquiring the same number of shares through options exercise. Following the transactions, Anderson directly owns 4,327 shares. The sale occurred while IDEX …
Dexcom director Nicholas Augustinos reported a gift of 1,075 shares of common stock to a charitable donor-advised fund on August 12, 2026. These shares were held indirectly through the Kirschner/Augustinos Revocable Trust, which now holds 37,382 shares. Additionally, Augustinos holds 5,575 unvested restricted stock …
Lisa Anderson, SVP at IDEX Corp., sold 385 shares for $91,859 on August 12, 2026, after acquiring the same number of shares through option exercise. This transaction occurred while IDEX stock is trading near its 52-week high and appears overvalued based on InvestingPro analysis. …
This page provides a detailed overview of DexCom Inc (MIL:1DXCM) stock, including its current price, market capitalization, P/E and P/B ratios, and key financial metrics. It highlights the company's financial strength, growth rank, profitability, and GF Value rank, along with recent news and upcoming …
Lisa M. Anderson, SVP, GC, CAO & Corporate Secretary at IDEX Corp (IEX), exercised options for 385 shares at $93.27 each and subsequently sold all 385 shares at a weighted average price of $238.5949 per share. The options were originally granted in 2018 and …
HAMBURG, GERMANY - August 13, 2026 (NEWMEDIAWIRE) - The Nordex Group has received orders from the EFG Energy Farming Group for the supply and installation of a total of twelve wind turbines for several citizen wind projects in Lower Saxony. The "Erlte-Endel" project in …
Codexis (CDXS) stock rallied 8.1% after its Q2 2026 earnings report, primarily due to management's revised expectation that its cash pile will fund operations through 2028, extending its cash runway. Despite this positive development, the company reported a US$12.0m net loss on US$14.9m in …
IDEX Corporation (IEX) has received strong buy ratings from analysts, with price targets around $280, indicating a potential upside of 15.20%. The company's fair value has been increased to $254.50, driven by updated assumptions for revenue growth and profit margins. IDEX has also been …
Walmart, Tesla, and more stocks will feel the effects of the capacity constraints, delays, and higher prices reported by shipping giants Maersk and Hapag-Lloyd. Continue Reading
Laurence W. Lytton has reported a beneficial ownership of 5,592,972 shares of Codexis, Inc. (CDXS) common stock, which represents a 5.2% stake in the company. This disclosure was made via a SCHEDULE 13G/A filing with the SEC, indicating an increase in his holdings above …
FedEx honored its founder, Fred Smith, on the first anniversary of his death by renaming the Memphis airport to Frederick W. Smith International Airport and unveiling a Boeing 777 freighter in the company's original 1973 livery. The event also marked the inaugural FedEx FWS …
Citigroup has increased its price target for DexCom (DXCM) shares to $105 from $88, while reiterating a Buy rating on the stock. This adjustment reflects a more optimistic outlook from the firm regarding the medical equipment company. DexCom specializes in continuous glucose monitoring systems …
Search by ticker symbol or company name and select a result to open its chart.